Current status of hepatic resection for hepatocellular carcinoma.
Hepatocellular carcinoma (HCC) is one of the most common tumors worldwide. For this disease, a variety of therapeutic measures have been applied, including hepatic resections, total hepatectomy followed by allografting, transarterial chemoembolization, and percutaneous tumor ablative therapy by ethanol, microwave coagulation, and radiofrequency ablation. This article focuses on the current status of hepatic resections for HCC.
Yanaga
Katsuhiko
K
Department of Surgery, Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan.
D006528:Carcinoma, Hepatocellular / Q000473:pathology / Q000601:surgery*; D016099:Endoscopy, Gastrointestinal; D006498:Hepatectomy / Q000401:mortality; D006801:Humans; D008103:Liver Cirrhosis; D008113:Liver Neoplasms / Q000473:pathology / Q000601:surgery*; D010166:Palliative Care; D011379:Prognosis; D012008:Recurrence